Page last updated: 2024-08-24

meglumine antimoniate and atovaquone

meglumine antimoniate has been researched along with atovaquone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Camara, L; Queirós, J; Ribeiro, R; Teófilo, E	1

Other Studies

1 other study(ies) available for meglumine antimoniate and atovaquone

Article	Year
Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients. BMJ case reports, 2019, Dec-16, Volume: 12, Issue:12 Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome	2019

Article

Year

Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients.

BMJ case reports, 2019, Dec-16, Volume: 12, Issue:12

Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome

2019